Skip to main content

Table 1 Epidemiological and clinical characteristics of the patient cohort. Numbers in brackets give the number of patients with complete datasets with regards to the specific items

From: Safety and clinical impact of FEES – results of the FEES-registry

General characteristics (N = 2236)
 Age 69.8 (14.6)
 Female gender 1013 (42.2)
 Barthel 35 (35.4))
 RASS −0.1 (0.81)
 Anticoagulation 451 (18.8)
 Anti-platelets 796 (33.2)
 Antithrombotic drugs 1005 (41.9)
Specific characteristics (N = 2330)
 Complex patients 1089 (45.4)
  Respiratory problems 279 (11.6)
  Tracheal cannula 447 (18.6)
  Agitation 161 (6.7)
  Disorientation 496 (20.7)
  Fluctuating vigilance 390 (16.2)
Main Diagnosis (N = 2401)
 Stroke 1465 (61.0)
 Stroke with Thrombolysis 393 (26.8)
 Parkinson’s Disease 157 (6.5)
 Critical-Illness Polyneuropathy 135 (5.6)
 Motorneuron Disorder 75 (3.1)
 Dementia 64 (2.7)
 Malignoma 48 (2.0)
 Movenent Disorders (other) 41 (1.7)
 Enzephalopathia 37 (1.5)
 Traumatic Brain Injury 36 (1.5)
 Meningitis/Enzephalitis 36 (1.5)
 Myasthenia gravis 35 (1.5)
 Immune-mediated neuropathy 34 (1.4)
 Psychogenic dysphagia 34 (1.4)
 Seizure 33 (1.4)
 Myopathy 29 (1.2)
 Cervical spine surgery 20 (0.8)
 Multiple Sclerosis 18 (0.7)
 Pneumonia 13 (0.5)
 Esophageal diseases 12 (0.5)
 Other/Missing 79 (3.3)